Haemonchosis (Barber's Pole Worm Infection)

Haemonchosis is a highly pathogenic parasitic gastroenteritis of sheep and goats caused by the abomasal nematode Haemonchus contortus, commonly known as the barber's pole worm due to the characteristic spiral appearance of the blood-filled intestine and white ovaries in the female worm. This blood-sucking parasite is the most economically important gastrointestinal nematode of small ruminants in tropical, subtropical, and warm temperate regions worldwide, causing acute anemia, hypoproteinemia, submandibular edema (bottle jaw), weight loss, and sudden death, particularly in young animals and periparturient ewes and does. The disease is classified as a primary parasitic gastroenteritis with a peracute, acute, or chronic presentation depending on the intensity of larval challenge and host immune status. In intensive dairy goat operations and range sheep flocks, haemonchosis is a major constraint to productivity, leading to reduced milk yield, poor growth rates, increased mortality, and substantial economic losses. The disease is particularly devastating in late gestation and early lactation when nutritional demands are high and host immunity is suppressed, resulting in a periparturient rise in fecal egg excretion and pasture contamination. Effective management requires an integrated approach combining targeted anthelmintic treatment, pasture management, genetic selection for resistance, and nutritional support.

The primary causative agent is Haemonchus contortus, a highly fecund trichostrongylid nematode of the family Trichostrongylidae. The adult female worm is 18-30 mm in length, while males are 10-20 mm, and both possess a lancet-like buccal capsule that lacerates the abomasal mucosa to feed on blood. The life cycle is direct, with no intermediate host. Adult females produce up to 5,000-10,000 eggs per day, which are passed in feces. Under optimal conditions (temperatures of 20-30°C and adequate moisture), eggs hatch into first-stage larvae (L1) within 24-48 hours, which then develop through L2 and infective L3 stages within 5-7 days. L3 larvae migrate onto herbage and are ingested by grazing animals. After ingestion, L3 exsheath in the rumen and penetrate the abomasal mucosa, where they undergo two molts to become L4 and then L5 (immature adults) within 2-3 weeks. The prepatent period is approximately 18-21 days. A unique feature of H. contortus is the ability of L4 larvae to undergo arrested development (hypobiosis) in the abomasal mucosa, particularly in response to adverse environmental conditions or host immunity, allowing survival over winter or dry seasons. These arrested larvae resume development in the periparturient period, contributing to the periparturient rise in egg output. Other species of Haemonchus, such as H. placei (primarily in cattle) and H. similis, are rarely of significance in small ruminants. Mixed infections with other trichostrongylids (Teladorsagia circumcincta, Trichostrongylus spp., Cooperia spp.) are common and may exacerbate clinical signs.

Haemonchosis is predominantly a disease of sheep and goats, with goats generally more susceptible and exhibiting higher fecal egg counts and more severe clinical disease than sheep. Breed susceptibility varies, with some breeds such as Gulf Coast Native, St. Croix, and Red Maasai sheep showing genetic resistance, while wool breeds like Merino and fine-wool crosses are highly susceptible. Age is a critical factor; lambs and kids aged 2-12 months are most vulnerable due to naïve immunity, while adult animals develop partial immunity after repeated exposure, although periparturient ewes and does experience a temporary loss of immunity. The disease is most prevalent in warm, moist climates, typically in spring, summer, and early autumn, when environmental conditions favor larval development and survival on pasture. In tropical and subtropical regions, transmission can occur year-round. The periparturient rise in fecal egg excretion in lactating dams is a major source of pasture contamination, leading to high larval challenge for lambs and kids. Morbidity can reach 75-90% in untreated flocks, and mortality can exceed 50% in severe outbreaks, particularly in young animals. Economic losses arise from mortality, reduced weight gain, decreased milk production, poor wool quality, and the cost of anthelmintic treatment. The emergence of anthelmintic resistance, particularly to macrocyclic lactones and benzimidazoles, has become a global concern, complicating control and increasing the risk of severe outbreaks.

The pathophysiology of haemonchosis is primarily due to blood loss from the abomasal mucosa. Adult worms feed by lacerating the mucosa with their buccal capsule and ingesting blood, with each worm consuming approximately 0.05 ml of blood per day. A heavy burden of 5,000 worms can result in a daily blood loss of 250 ml, leading to acute anemia and hypoproteinemia. The parasite secretes anticoagulant compounds, including a platelet-aggregation inhibitor and a thrombin inhibitor, which prolong bleeding from the attachment sites. The host responds to blood loss by increasing erythropoiesis, but in acute infections, the bone marrow cannot compensate, resulting in severe anemia. The loss of plasma proteins, particularly albumin, leads to hypoalbuminemia and oncotic pressure reduction, causing subcutaneous edema, especially in the submandibular region (bottle jaw) and ventral abdomen. In chronic infections, iron deficiency anemia develops due to depletion of iron stores. The abomasal mucosa shows hyperemia, edema, and petechial hemorrhages at attachment sites. The host immune response involves Th2-type cytokines (IL-4, IL-5, IL-13), eosinophilia, and mast cell hyperplasia, but these responses are often ineffective in preventing blood loss. In periparturient animals, immunosuppression associated with pregnancy and lactation allows a rapid increase in worm burden and egg output. The nutritional status of the host influences the severity of disease; protein-energy malnutrition exacerbates anemia and hypoproteinemia, while adequate protein intake can improve resilience.

Intrinsic factors include young age (lambs and kids), breed susceptibility, genetic predisposition, and periparturient immunosuppression. Extrinsic factors include grazing on contaminated pastures, high stocking density, warm and humid weather, and inadequate nutrition. Management practices that contribute to the disease include failure to implement targeted selective treatment, lack of pasture rotation, and over-reliance on anthelmintics leading to resistance. The periparturient rise in fecal egg output is a major risk factor for pasture contamination. In goats, higher susceptibility is partly due to lower immune responsiveness and different grazing behavior (browsing) that may increase exposure. Poor body condition score (BCS <2) and concurrent diseases (e.g., caseous lymphadenitis, ovine progressive pneumonia) increase susceptibility. Anthelmintic resistance is a critical predisposing factor, as resistant worm populations survive treatment and continue to cause disease.

Clinical signs vary with the intensity of infection and the host's immune and nutritional status. In peracute cases, sudden death may occur without premonitory signs, particularly in lambs with overwhelming larval challenge. Acute haemonchosis is characterized by severe anemia, pale mucous membranes, lethargy, weakness, and exercise intolerance. The FAMACHA anemia scoring system is a practical tool for assessing anemia in sheep and goats, with scores ranging from 1 (normal red) to 5 (severely pale). Affected animals may have a submandibular edema (bottle jaw) and ventral edema due to hypoproteinemia. Weight loss, poor growth, and decreased milk production are common. In chronic cases, animals may show progressive emaciation, diarrhea (often soft or pasty), and rough hair coat. In periparturient ewes and does, clinical signs may be masked by the demands of lactation, but they may exhibit reduced milk yield and poor body condition. Neurological signs are not typical but may occur secondary to severe anemia and weakness. In goats, clinical signs are similar but may progress more rapidly. The flock history often reveals a recent move to contaminated pasture or a period of warm, wet weather.

Differential diagnoses include other causes of anemia and weight loss in small ruminants: 1) Other gastrointestinal nematodes (Teladorsagia, Trichostrongylus, Cooperia) - these cause similar signs but are less pathogenic and do not cause severe anemia; differentiation by fecal egg count and larval culture. 2) Fascioliasis (liver fluke) - causes anemia, hypoalbuminemia, and bottle jaw, but is associated with wet pasture and snails; diagnosis by fecal sedimentation for fluke eggs or ELISA. 3) Coccidiosis - primarily affects young animals, causing diarrhea and weight loss, but anemia is less prominent; diagnosis by fecal oocyst count and intestinal lesions. 4) Johne's disease (paratuberculosis) - chronic wasting and diarrhea in adult animals, but anemia is not a primary feature; diagnosis by PCR or ELISA. 5) Caseous lymphadenitis (CLA) - chronic weight loss and abscesses in lymph nodes; diagnosis by culture or PCR. 6) Ovine progressive pneumonia (maedi-visna) - chronic respiratory disease and weight loss; diagnosis by serology. 7) Nutritional deficiencies (copper, cobalt, vitamin B12) - cause anemia and ill-thrift; diagnosis by blood and liver mineral analysis. 8) Pregnancy toxemia - in late gestation, causes neurological signs and ketonemia, but not anemia; diagnosis by blood BHB. 9) Bacterial septicemia (e.g., Pasteurella) - acute fever and respiratory signs, but anemia is not typical. 10) Plant poisoning (e.g., bracken fern) - causes bone marrow suppression and anemia, but history of access to toxic plants.

The diagnostic approach begins with a thorough flock history, including grazing management, anthelmintic use, and recent weather. Physical examination of affected animals should include assessment of mucous membrane color using the FAMACHA card, presence of submandibular edema, body condition score, and fecal consistency. A fecal sample should be collected for quantitative fecal egg count (FEC) using the McMaster technique; counts >2,000 eggs per gram (EPG) in sheep or >4,000 EPG in goats are indicative of significant infection. Larval culture can be performed to identify Haemonchus species based on larval morphology. In periparturient animals, FEC may be lower due to hypobiosis, but the periparturient rise is a key indicator. Blood samples should be taken for packed cell volume (PCV) and total protein; PCV <20% indicates severe anemia. FAMACHA scoring can be used to identify anemic animals for targeted treatment. Necropsy of a representative animal is valuable; findings include pale carcass, watery blood, and abomasal mucosa with numerous small red worms (barber's pole appearance). Histopathology of the abomasum may show mucosal hyperplasia and eosinophilic infiltration. Anthelmintic resistance testing (fecal egg count reduction test, FECRT) should be performed if treatment failure is suspected. The diagnostic algorithm should be systematic, ruling out other causes of anemia and wasting.

Hematology reveals regenerative anemia with decreased PCV (often <20%), decreased hemoglobin, and increased reticulocyte count in chronic cases. Total protein and albumin are decreased due to protein loss. Serum iron may be decreased in chronic iron deficiency. Eosinophilia may be present. Fecal egg count is elevated, typically >2,000 EPG in sheep and >4,000 EPG in goats, but can be lower in periparturient animals. Larval culture confirms Haemonchus contortus. Blood glucose and BHB are usually within normal limits unless concurrent pregnancy toxemia. Serum copper and cobalt levels may be low if nutritional deficiencies coexist. In periparturient animals, BHB may be elevated if pregnancy toxemia is present. CSF analysis is not typically performed unless neurological signs are present, in which case it may be normal or show mild protein elevation. PCR on feces can detect Haemonchus species and anthelmintic resistance-associated mutations (e.g., beta-tubulin gene for benzimidazole resistance).

Imaging is not commonly used in the diagnosis of haemonchosis. Ultrasonography may be used to assess the abomasum, but findings are nonspecific. In cases of bottle jaw, ultrasound can confirm subcutaneous edema. Thoracic and abdominal ultrasound may be performed to rule out other causes of weight loss, such as chronic pneumonia or liver disease. Radiography is rarely indicated. Computed tomography is not used in routine practice. In research settings, ultrasonography has been used to measure abomasal wall thickness, but this is not a standard diagnostic tool.

Histopathology of the abomasum shows mucosal hyperplasia, goblet cell hyperplasia, and infiltration of eosinophils, mast cells, and lymphocytes. The mucosa may have erosions and hemorrhages at attachment sites. Adult worms may be seen in sections. In chronic cases, there may be fibrosis and atrophy of the abomasal glands. Lymph node cytology may show eosinophilia and reactive changes. Bone marrow aspirates may show erythroid hyperplasia in response to anemia. In cases of concurrent disease, histopathology of other organs may reveal additional findings.

Treatment of haemonchosis involves the use of anthelmintics, but due to widespread resistance, the choice of drug should be based on efficacy testing. Effective anthelmintics include: 1) Benzimidazoles (e.g., albendazole, fenbendazole) at 10 mg/kg PO; resistance is common. 2) Imidazothiazoles (levamisole) at 8 mg/kg PO or SC; resistance is less common but increasing. 3) Macrocyclic lactones (ivermectin, moxidectin) at 0.2 mg/kg PO or SC; resistance is widespread in many regions. 4) Amino-acetonitrile derivatives (monepantel) at 2.5 mg/kg PO; resistance is emerging. 5) Spiroindoles (derquantel) in combination with abamectin. 6) Salicylanilides (closantel) at 10 mg/kg PO; effective against Haemonchus but not other nematodes. 7) Organophosphates (naphthalophos) are rarely used. In severe cases, supportive treatment is essential: administer iron dextran (20 mg/kg IM) and B-complex vitamins. Provide high-quality protein supplementation to replace lost protein. In periparturient animals, ensure adequate nutrition and consider reducing milk demand. In cases of severe anemia (PCV <15%), blood transfusion may be life-saving, but is rarely practical in the field. Anthelmintic treatment should be followed by a fecal egg count reduction test (FECRT) to assess efficacy. If resistance is suspected, a combination of anthelmintics from different classes may be used, but this should be done with veterinary guidance. Pasture management is crucial to prevent reinfection; move animals to clean pasture after treatment.

The prognosis for haemonchosis depends on the severity of anemia and the promptness of treatment. With early treatment and supportive care, the prognosis is good, and animals can recover within 2-4 weeks. However, in peracute cases with severe anemia (PCV <10%) or in animals with concurrent diseases, the prognosis is guarded to poor. Chronic cases may have a prolonged recovery and may suffer from reduced productivity. The prognosis is also influenced by the presence of anthelmintic resistance; if treatment is ineffective, the prognosis is poor. In flocks with a high prevalence of resistance, the long-term prognosis is poor unless management changes are implemented. For individual animals, the FAMACHA score and PCV are useful prognostic indicators; animals with a FAMACHA score of 4-5 and PCV <15% have a poorer prognosis. With appropriate treatment and management, the flock prognosis can be good if anthelmintic resistance is managed and pasture contamination is reduced.

After treatment, animals should be monitored for clinical improvement, including mucous membrane color, appetite, and weight gain. A fecal egg count should be performed 10-14 days after treatment to assess efficacy; a reduction of >95% is expected if the anthelmintic is effective. If the reduction is <95%, anthelmintic resistance is suspected, and alternative drugs should be considered. In periparturient animals, monitor milk production and body condition. Implement a targeted selective treatment (TST) program using FAMACHA scoring to treat only anemic animals, reducing selection pressure for resistance. Pasture management is critical: rotate pastures to allow larval die-off, avoid overgrazing, and consider mixed grazing with cattle or horses. In goats, consider genetic selection for resistance. Regular monitoring of FEC and FAMACHA scores should be conducted throughout the grazing season. In endemic areas, vaccination with a recombinant H. contortus antigen (Barbervax) is available in some countries and can be used as part of an integrated control program.

Pearls: 1) FAMACHA scoring is a rapid, cost-effective tool for identifying anemic animals and targeting treatment, reducing anthelmintic use and slowing resistance. 2) The periparturient rise in FEC is a key source of pasture contamination; treat ewes/does at lambing/kidding to reduce larval challenge to lambs/kids. 3) In goats, use higher FEC thresholds for treatment decisions due to their higher susceptibility. 4) Always perform a FECRT to confirm anthelmintic efficacy, as resistance is common. 5) Combine anthelmintic treatment with nutritional support, especially protein supplementation, to improve recovery. 6) Use a combination of anthelmintics with different mechanisms of action if resistance is suspected, but only under veterinary guidance. Pitfalls: 1) Underdosing anthelmintics is a major cause of resistance; always weigh animals accurately and dose to the heaviest animal. 2) Moving animals to clean pasture immediately after treatment can select for resistant worms if the pasture is contaminated; instead, treat and keep animals on contaminated pasture for 24-48 hours to allow susceptible worms to be shed. 3) Over-reliance on a single anthelmintic class leads to resistance; rotate classes annually or use targeted selective treatment. 4) Ignoring the role of nutrition in resilience; animals on a low-protein diet are more susceptible to disease. 5) Failing to consider concurrent infections (e.g., coccidiosis, liver fluke) can lead to misdiagnosis and treatment failure. 6) In goats, using sheep dosages may be inadequate; goats often require higher doses due to differences in drug metabolism.

Anthelmintic protocols for haemonchosis in sheep and goats (based on Plumb's Veterinary Drug Handbook and AASRP guidelines): 1) Albendazole: 10 mg/kg PO once; withdrawal times: meat 7 days, milk 3 days (sheep); goats may require 15-20 mg/kg. 2) Fenbendazole: 10 mg/kg PO once; withdrawal times: meat 6 days, milk 3 days (sheep); goats may require 15-20 mg/kg. 3) Levamisole: 8 mg/kg PO or SC once; withdrawal times: meat 3 days, milk 3 days (sheep); goats: 12 mg/kg. 4) Ivermectin: 0.2 mg/kg PO or SC once; withdrawal times: meat 11 days, milk 4 days (sheep); goats: 0.3 mg/kg. 5) Moxidectin: 0.2 mg/kg PO or SC once; withdrawal times: meat 7 days, milk 4 days (sheep); goats: 0.4 mg/kg. 6) Closantel: 10 mg/kg PO once; withdrawal times: meat 28 days, milk 14 days (sheep); goats: 10 mg/kg. 7) Monepantel: 2.5 mg/kg PO once; withdrawal times: meat 7 days, milk 5 days (sheep); goats: 2.5 mg/kg. 8) Derquantel/abamectin: 0.1 mg/kg derquantel + 0.2 mg/kg abamectin PO once; withdrawal times: meat 7 days, milk 4 days (sheep). Supportive therapy: Iron dextran: 20 mg/kg IM once; B-complex vitamins: 2-5 mL IM; in severe anemia, consider blood transfusion. For periparturient animals, ensure adequate energy and protein intake; if pregnancy toxemia is concurrent, administer propylene glycol 60 mL PO q12h and 50% dextrose 100-200 mL IV slowly. Always follow label directions and consult a veterinarian for specific protocols.

Haemonchosis is a well-studied disease, and numerous clinical trials and field studies have evaluated control strategies. Key findings include: 1) Targeted selective treatment (TST) using FAMACHA scoring is effective in reducing anthelmintic use while maintaining animal health and productivity (Kaplan et al., 2004; Burke et al., 2007). 2) Anthelmintic resistance is widespread, with high levels of resistance to benzimidazoles and macrocyclic lactones reported in many regions (Falzon et al., 2014; Geurden et al., 2015). 3) Genetic selection for resistance is feasible, with heritability estimates for FEC ranging from 0.2 to 0.4 in sheep (Bishop et al., 1996). 4) Vaccination with Barbervax (a native gut membrane glycoprotein vaccine) has shown efficacy in reducing FEC and worm burden in sheep (Smith et al., 2009). 5) Nutrition plays a critical role in resilience; protein supplementation improves resistance and resilience to haemonchosis (Coop and Kyriazakis, 1999). 6) Pasture management, including rotational grazing and mixed species grazing, can reduce larval contamination and the need for anthelmintics (Niezen et al., 1996). 7) The periparturient rise is a key target for control; treating ewes at lambing reduces pasture contamination (Barger, 1993). 8) In goats, higher doses of anthelmintics are often required due to differences in pharmacokinetics (Gokbulut et al., 2010). Consensus guidelines from AASRP and ECSRHM recommend integrated parasite management (IPM) combining TST, pasture management, genetic selection, and vaccination where available.